Danazol therapy: an unusual aetiology of hepatocellular carcinoma
letter
OA: closed
CC0
⤵ 5 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper presents a case of hepatocellular carcinoma with an unusual etiology attributed to danazol therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (4)
- An apparent danazol‐induced primary hepatocellular carcinoma: Case report via openalex
- DANAZOL AND HEPATIC NEOPLASIA: A CASE REPORT via openalex
- Hepatocellular carcinoma after danazol therapy. via openalex
- doi:10.1055/s-2008-1040579 via openalex
Cited by (5)
- Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog 2016
- Danazol induced acute icteric cholestatic hepatitis 2007
- Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions 2004
- Danazol‐induced hepatocellular carcinoma 2003
- Hepatocellular adenoma and focal nodular hyperplasia after long-term use of danazol for endometriosis: a case report 2002
Source provenance
- openalex
- last seen: 2026-05-11T03:42:44.496353+00:00
License: CC0
· commercial use OK